Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Prevalence of Long COVID-19 in the Canary Islands

  • Read more about Prevalence of Long COVID-19 in the Canary Islands

Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic

  • Read more about Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic

Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid

  • Read more about Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid

Impact of External Factors(Brexit and Covid-19) on Retention and Turnover in the NHS

  • Read more about Impact of External Factors(Brexit and Covid-19) on Retention and Turnover in the NHS

Nitrite Supplementation in Long COVID Patients

  • Read more about Nitrite Supplementation in Long COVID Patients

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in

  • Read more about A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

  • Read more about A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)

  • Read more about UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)

Immune Responses to COVID-19 Infection or Vaccination

  • Read more about Immune Responses to COVID-19 Infection or Vaccination

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

  • Read more about Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 179
  • Page 180
  • Page 181
  • Page 182
  • Current page 183
  • Page 184
  • Page 185
  • Page 186
  • Page 187
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA